Stephen L Yates

Title: The Innovations of Stephen L. Yates

Introduction

Stephen L. Yates is a notable inventor based in Aurora, OH, with a significant contribution to the field of histamine receptor research. He holds a total of four patents, showcasing his innovative approach to understanding and manipulating histamine receptors.

Latest Patents

Yates' latest patents include groundbreaking work on histamine receptor H3 polynucleotides. These patents describe novel splice variants of the human H3 histamine receptor, which feature deletions of portions of the N-terminal of the wild type H3 receptor. These splice variants are instrumental in methods for identifying agonists, inverse agonists, or antagonists of histamine action at the H3 receptor. Additionally, he has developed patents related to histamine receptor H4 polynucleotides, which also describe novel splice variants of the human H4 histamine receptor. Similar to the H3 receptor, these variants have deletions of portions of the N-terminal of the wild type H4 receptor and are useful in identifying various agents that interact with the H4 receptor.

Career Highlights

Throughout his career, Stephen L. Yates has worked with prominent companies such as Gliatech, Inc. and Merck & Company, Inc. His work in these organizations has contributed to advancements in pharmaceutical research and development.

Collaborations

Yates has collaborated with notable colleagues, including James G. Phillips and Clark E. Tedford, further enhancing the impact of his research and innovations.

Conclusion

Stephen L. Yates is a distinguished inventor whose work on histamine receptors has paved the way for new therapeutic approaches. His contributions to the field are significant and continue to influence research in pharmacology.